About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Daito Pharmaceutical Co.,Ltd.(4577) Summary

4577
TSE Prime
Daito Pharmaceutical Co.,Ltd.
2,025
JPY
+7
(+0.35%)
Dec 23, 3:30 pm JST
12.93
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
13.4
PBR
0.60
Yield
3.46%
Margin Trading Ratio
57.10
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
2,011 JPY 12.84 USD
Previous Close Dec 20
2,018 JPY 12.86 USD
High Dec 23, 1:26 pm
2,035 JPY 12.99 USD
Low Dec 23, 10:58 am
1,999 JPY 12.77 USD
Volume
29,900
Trading Value
0.06B JPY 0.39M USD
VWAP
2017.75 JPY 12.89 USD
Minimum Trading Value
202,500 JPY 1,293 USD
Market Cap
0.03T JPY 0.20B USD
Number of Trades
165
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Mid
1-Year Average
238
1-Year High Apr 15, 2024
938
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 500 63,500 127.00
Dec 6, 2024 500 58,300 116.60
Nov 29, 2024 700 59,300 84.71
Nov 22, 2024 1,000 57,100 57.10
Nov 15, 2024 1,600 60,000 37.50
Company Profile
Daito Pharmaceutical Co., Ltd. specializes in the manufacturing of active pharmaceutical ingredients (APIs) and contract manufacturing of pharmaceutical products, primarily serving generic drug manufacturers.
Sector
Pharmaceuticals